Literature DB >> 9135076

Characterization, expression and chromosomal localization of a human gene homologous to the mouse Lsc oncogene, with strongest expression in hematopoetic tissues.

H C Aasheim1, F Pedeutour, E B Smeland.   

Abstract

A human cDNA clone, denoted sub1.5, was isolated from cDNA library generated from human T cells. The sub1.5 cDNA sequence was novel and was not identical to any known cDNA sequences in the GenBank. Recently, however, a mouse cDNA (Lsc) with high homology to sub1.5 was identified, indicating that the sub1.5 sequence may represent the human homologue of the mouse Lsc gene. The sub1.5 cDNA includes an open reading frame of 875 amino acids, predicting a protein with molecular weight of 97 kDa. Like Lsc, sub1.5 shows homology to the previous described oncogene Lbc, in particular to two functional domains in the Lbc protein; the Dbl proto-oncogene homology domain and the pleckstrin homology domain. Lsc is proposed to be an oncogene and is a member of a growing family of proteins that may function as activators of the Rho family GTPases. Members of the Rho family regulates the polymerization of actin to produce stress fibers. Activation of Rho GTPases by sub1.5 is also indicated by our studies, as stress fiber formation is observed in serum-starved stable NIH3T3 sub1.5 transfectants. Sub1.5 cDNA hybridizes to two major transcripts of 3.5 and 5 kb size and the strongest expression is seen in hematopoietic tissues like thymus, lymph nodes, peripheral blood leukocytes and spleen. We also show that both purified B and T cells express sub1.5. In addition, our data indicate that sub1.5 mRNA is abundantly expressed in CD34+ human progenitor cells. Fluorescent in situ hybridisation, using sub1.5 cDNA as a probe on human metaphases, shows that the sub1.5 gene is localized to chromosome 19q13.13.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135076     DOI: 10.1038/sj.onc.1200994

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Modulation of HIV-1 replication by a novel RhoA effector activity.

Authors:  L Wang; H Zhang; P A Solski; M J Hart; C J Der; L Su
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

2.  Lsc activity is controlled by oligomerization and regulates integrin adhesion.

Authors:  Jiancheng Hu; Pamela Strauch; Anatoly Rubtsov; Erin E Donovan; Roberta Pelanda; Raul M Torres
Journal:  Mol Immunol       Date:  2007-12-21       Impact factor: 4.407

Review 3.  Regulation and physiological functions of G12/13-mediated signaling pathways.

Authors:  Nobuchika Suzuki; Nicole Hajicek; Tohru Kozasa
Journal:  Neurosignals       Date:  2009-02-12

4.  Arhgef1 regulates alpha5beta1 integrin-mediated matrix metalloproteinase expression and is required for homeostatic lung immunity.

Authors:  John M Hartney; Jeanette Brown; Hong Wei Chu; Ling Yi Chang; Roberta Pelanda; Raul M Torres
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

5.  Loss of ARHGEF1 causes a human primary antibody deficiency.

Authors:  Amine Bouafia; Sébastien Lofek; Julie Bruneau; Loïc Chentout; Hicham Lamrini; Amélie Trinquand; Marie-Céline Deau; Lucie Heurtier; Véronique Meignin; Capucine Picard; Elizabeth Macintyre; Olivier Alibeu; Marc Bras; Thierry Jo Molina; Marina Cavazzana; Isabelle André-Schmutz; Anne Durandy; Alain Fischer; Eric Oksenhendler; Sven Kracker
Journal:  J Clin Invest       Date:  2019-02-04       Impact factor: 14.808

Review 6.  The effect of membrane domains on the G protein-phospholipase Cbeta signaling pathway.

Authors:  Urszula Golebiewska; Suzanne Scarlata
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-04       Impact factor: 8.250

7.  Arhgef1 is required by T cells for the development of airway hyperreactivity and inflammation.

Authors:  Jeanette P Brown; Christian Taube; Nobuaki Miyahara; Toshiyuki Koya; Roberta Pelanda; Erwin W Gelfand; Raul M Torres
Journal:  Am J Respir Crit Care Med       Date:  2007-04-26       Impact factor: 21.405

8.  Expression of p114RhoGEF predicts lymph node metastasis and poor survival of squamous-cell lung carcinoma patients.

Authors:  Chengyang Song; Ying Gao; Ye Tian; Xu Han; Yong Chen; Da-Li Tian
Journal:  Tumour Biol       Date:  2013-03-20

9.  Integrative multiomics and in silico analysis revealed the role of ARHGEF1 and its screened antagonist in mild and severe COVID-19 patients.

Authors:  Prakash Jha; Prithvi Singh; Shweta Arora; Armiya Sultan; Arnab Nayek; Kalaiarasan Ponnusamy; Mansoor Ali Syed; Ravins Dohare; Madhu Chopra
Journal:  J Cell Biochem       Date:  2022-01-17       Impact factor: 4.480

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.